DRAP REGISTERED MEDICAL DEVICE
Mosovisc (hyaluronic acid) [4ml Volume] is registered with DRAP under number MDIR-0003713 as a Class D (high risk) medical device, imported. The listed holder is Bionta Pharma. It is listed as valid until 24 Aug 2027.
Screening result
i
Number type: imported, registered (Class B, C or D)
MDIR-0003713
MDIR-0003713
✓
Found in DRAP's published list
DRAP registered Class B/C/D list, 28 Aug 2025
DRAP registered Class B/C/D list, 28 Aug 2025
✓
Listed valid until 24 Aug 2027
✓
Holder has a DRAP import licence on file
ELI-00367
ELI-00367
| Device | Mosovisc (hyaluronic acid) [4ml Volume] |
|---|---|
| Class | D |
| Listed holder | Bionta Pharma |
| Holder address | Suit No. A-10, Plot No. B-10, Gulshan-e-Iqbal Karachi |
| Manufacturing site | M/s Anika Therapeutics, Inc. 32 Wiggins Avenue, Bedford MA, 01730, USA. |
| Issued | 25 Aug 2022 |
| Renewal date | 24 Aug 2027 |
| Licence | ELI-00367 |
Specifications
No supplier specifications yet.
Supplier of this device? Add specifications (free during launch)
Sign in or create a free account to add specifications.
Screened 5 Oct 2026, 08:52 (Pakistan time). A screening aid, not an official DRAP verification.
More devices from this holder
Other DRAP registrations and enlistments listed for the same company.
| MDIR-0004493 | Cingal injection (Cross-linked sodium hyaluronate Triamcinolone hexacetonide) [4ml] | Class D |
| MDIR-0004494 | Orthovisc (hyaluronic acid) [15mg/ml, 2ml Volume 15mg/ml, 1ml Volume] | Class D |
Corrections
Is something on this page wrong? Report a correction
Corrections are checked against the evidence before anything changes on this page.
Screen another number
Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.